ClinicalTrials.Veeva

Menu

Mixed Local for Sciatic Block

L

Lawson Health Research Institute

Status

Not yet enrolling

Conditions

Local Anesthetic
Regional Anesthesia

Treatments

Drug: Ropivacaine 0,5%
Drug: Ropivacaine and Lidocaine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Choice of local anesthetics is the major determinant of the characteristics of a peripheral nerve block. Short acting local anesthetics while provides faster onset suffer from shorter duration. On the other hand, long acting local anesthetics while provides long duration suffered from long onset time. The ideal local anesthetics should provide faster nerve block onset while providing reasonable duration to provide sustained postoperative analgesia. Mixing short and long acting local anesthetics for nerve blocks may appear to be the solution however previous published studies have demonstrated similar onset time to long acting local anesthetics and with reduced duration. Recently, the London Health Sciences Centre established an ambulatory surgical centre. Fast onset peripheral nerve block is desirable. Previous studies have not looked at popliteal sciatic block and anecdotally we feel addition of short acting local anesthetics appear to speed up onset. We are therefore interested in conducting a randomize trial to determine whether mixing short and long acting local anesthetics can speed up onset of surgical quality block.

Enrollment

110 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (≥18 years old)
  • Scheduled for elective below-knee surgeries such as ankle arthroscopy, lower limb fracture fixation, toe surgeries, etc
  • Capable of providing informed consent

Exclusion criteria

  • History of allergic reaction to local anesthetics
  • Pre-existing neurological disorders affecting lower limbs
  • Significant renal or hepatic impairment
  • Pregnancy or breastfeeding
  • Less than 60kg
  • Inability to provide informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

110 participants in 2 patient groups

Ropivacaine
Active Comparator group
Description:
Popliteal block using Ropivacaine 100 mg in 20 mL
Treatment:
Drug: Ropivacaine 0,5%
Ropivacaine anmd Lidocaine
Experimental group
Description:
Popliteal sciatic block using Ropivacaine 100 mg and Lidocaine 100 mg in 20 mL
Treatment:
Drug: Ropivacaine and Lidocaine

Trial contacts and locations

0

Loading...

Central trial contact

Cheng Lin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems